Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: Vancomycin Study in Multiple Sclerosis (MS) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating vancomycin for multiple sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vancomycin (vancomycin)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Multiple Sclerosis | Phase 1 | Status: RECRUITING